Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 42, Pages 16832-16837Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1311528110
Keywords
endangered plants; hepatitis C virus; diabetes mellitus
Categories
Funding
- National Institutes of Health (NIH)
- National Center for Complementary and Alternative Medicine (NCCAM) [R01-AT-007318]
- National Center for Research Resources (NCRR) [CO6-RR-145503]
- Kraft Foods Group, Inc.
- Ministry of Higher Education and Scientific Research-Egypt
- Department of Veterans Affairs
- NIH Centers for AIDS Research (CFAR) [2P30-AI-050409]
- National Research Foundation of Korea (NRF) [NRF-C1ABA001-2010-0020484]
Ask authors/readers for more resources
One in five of the world's plant species is threatened with extinction according to the 2010 first global analysis of extinction risk. Tilman et al. predicted a massive ecological change to terrestrial plants within the next 50-100 y, accompanied by an increase in the number of global plant species facing extinction [Tilman D, et al. (2001) Proc Natl Acad Sci USA 98(10): 5433-5440]. Most of the drug-producing plant families contain endangered species never previously studied for their utility to human health, which strongly validates the need to prioritize protection and assessment of these fragile and endangered groups [Zhu F, et al. (2011) Proc Natl Acad Sci USA 108(31): 12943-12948]. With little prior attention given to endangered and rare plant species, this report provides strong justification for conservation of the rare plant Diplostephium rhododendroides Hieron., as well as other potential drug-producing endangered species in this and other groups.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available